Filters
reset allOther countries
Results: 1 to 10 of 10
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
ABL1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Invitae Connective Tissue Disorders Panel Invitae United States | 195 | 92 |
|
Comprehensive Panel for Individualized Cancer Threatment GeneKor MSA Greece | 16 | 52 |
|
Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing ARUP Laboratories, Molecular Oncology ARUP Laboratories United States | 6 | 65 |
|
Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center United States | 11 | 2 |
|
Fulgent Genetics United States | 3 | 1 |
|
Hemato-oncology chromosomal microarray Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center United States | 23 | 93 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Results: 1 to 10 of 10
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.